Ongoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$36,678 Объем
31 дек. 2026 г.
South Sudan
69%
Rwanda
23%
Burundi
25%
United States
21%
Canada
25%
Kenya
33%
India
15%
Republic of the Congo
25%
Nigeria
44%
Ethiopia
50%
Somalia
36%
China
13%
$36,678 Объем
South Sudan
$3,363 Объем
69%
Rwanda
$2,128 Объем
23%
Burundi
$202 Объем
25%
United States
$10,507 Объем
21%
Canada
$1,543 Объем
25%
Kenya
$235 Объем
33%
India
$732 Объем
15%
Republic of the Congo
$12,281 Объем
25%
Nigeria
$25 Объем
44%
Ethiopia
$107 Объем
50%
Somalia
$71 Объем
36%
China
$3,529 Объем
13%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Открытие рынка: May 22, 2026, 12:35 PM ET
Объем
$36,678Дата окончания
1 янв. 2027 г.Открытие рынка
May 22, 2026, 12:35 PM ETКто определяет исход
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Объем
$36,678Дата окончания
1 янв. 2027 г.Открытие рынка
May 22, 2026, 12:35 PM ETКто определяет исход
0x65070BE91...Ongoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы